Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tomohiro Iida

Showing results (191-200 of 219) with videos related to

Pageof 22
Sort By:
Investigative Ophthalmology & Visual Science|May 4, 2010
Single-nucleotide polymorphisms in the promoter region of matrix metalloproteinase-1, -2, and -3 in Japanese with high myopiaHideo Nakanishi, Hisako Hayashi, Ryo Yamada, et al.
BMJ Open|April 21, 2026
Reduced-fluence photodynamic therapy versus placebo for central serous chorioretinopathy (REPLAY trial): rationale and study protocol of a pivotal double-blind randomised controlled trialMasahiro Miyake, Ayako Takahashi, Takayuki Baba, et al.
Ophthalmology|March 29, 2011
Genetic variants in pigment epithelium-derived factor influence response of polypoidal choroidal vasculopathy to photodynamic therapyIsao Nakata, Kenji Yamashiro, Ryo Yamada, et al.
Ophthalmology. Retina|June 11, 2023
Clinical Characteristics and Progression of Geographic Atrophy in a Japanese PopulationYukiko Sato, Naoko Ueda-Arakawa, Ayako Takahashi, et al.
Asia-Pacific Journal of Ophthalmology (Philadelphia, Pa.)|January 10, 2026
Intravitreal aflibercept 8 mg versus 2 mg in Asian patients with neovascular age-related macular degeneration: 48-week analysis of the Phase 3 PULSAR trialAndrew Chang, Xiaodong Sun, Tomohiro Iida, et al.
Ophthalmology Science|June 3, 2024
Clinical Characteristics and Progression of Pachychoroid and Conventional Geographic AtrophyYukiko Sato, Naoko Ueda-Arakawa, Ayako Takahashi, et al.
Plos One|February 25, 2022
Progression of age-related macular degeneration in eyes with abnormal fundus autofluorescence in a Japanese population: JFAM study report 3Yuji Oshima, Ari Shinojima, Miki Sawa, et al.
Ophthalmology Science|December 24, 2025
Impact of Reticular Pseudodrusen on Clinical and Ocular Characteristics and Progression Rate of Geographic Atrophy in Japanese PatientsNaoko Ueda-Arakawa, Yukiko Sato, Masahiro Miyake, et al.
Retina (Philadelphia, Pa.)|March 5, 2013
Polypoidal choroidal vasculopathy: evidence-based guidelines for clinical diagnosis and treatmentAdrian H C Koh, , Lee-Jen Chen, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|January 16, 2022
Subfoveal choroidal thickness after brolucizumab therapy for neovascular age-related macular degeneration: a short-term multicenter studyTamaki Tamashiro, Koji Tanaka, Kanako Itagaki, et al.
Pageof 22

Showing results (191-200 of 219) with videos related to

Sort By:
Pageof 22
Investigative Ophthalmology & Visual Science|May 4, 2010
Single-nucleotide polymorphisms in the promoter region of matrix metalloproteinase-1, -2, and -3 in Japanese with high myopiaHideo Nakanishi, Hisako Hayashi, Ryo Yamada, et al.
BMJ Open|April 21, 2026
Reduced-fluence photodynamic therapy versus placebo for central serous chorioretinopathy (REPLAY trial): rationale and study protocol of a pivotal double-blind randomised controlled trialMasahiro Miyake, Ayako Takahashi, Takayuki Baba, et al.
Ophthalmology|March 29, 2011
Genetic variants in pigment epithelium-derived factor influence response of polypoidal choroidal vasculopathy to photodynamic therapyIsao Nakata, Kenji Yamashiro, Ryo Yamada, et al.
Ophthalmology. Retina|June 11, 2023
Clinical Characteristics and Progression of Geographic Atrophy in a Japanese PopulationYukiko Sato, Naoko Ueda-Arakawa, Ayako Takahashi, et al.
Asia-Pacific Journal of Ophthalmology (Philadelphia, Pa.)|January 10, 2026
Intravitreal aflibercept 8 mg versus 2 mg in Asian patients with neovascular age-related macular degeneration: 48-week analysis of the Phase 3 PULSAR trialAndrew Chang, Xiaodong Sun, Tomohiro Iida, et al.
Ophthalmology Science|June 3, 2024
Clinical Characteristics and Progression of Pachychoroid and Conventional Geographic AtrophyYukiko Sato, Naoko Ueda-Arakawa, Ayako Takahashi, et al.
Plos One|February 25, 2022
Progression of age-related macular degeneration in eyes with abnormal fundus autofluorescence in a Japanese population: JFAM study report 3Yuji Oshima, Ari Shinojima, Miki Sawa, et al.
Ophthalmology Science|December 24, 2025
Impact of Reticular Pseudodrusen on Clinical and Ocular Characteristics and Progression Rate of Geographic Atrophy in Japanese PatientsNaoko Ueda-Arakawa, Yukiko Sato, Masahiro Miyake, et al.
Retina (Philadelphia, Pa.)|March 5, 2013
Polypoidal choroidal vasculopathy: evidence-based guidelines for clinical diagnosis and treatmentAdrian H C Koh, , Lee-Jen Chen, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|January 16, 2022
Subfoveal choroidal thickness after brolucizumab therapy for neovascular age-related macular degeneration: a short-term multicenter studyTamaki Tamashiro, Koji Tanaka, Kanako Itagaki, et al.
Pageof 22